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The KDIGO urine output criteria for acute kidney injury (AKI) have been shown to lack 
specificity for identifying patients at risk of adverse renal outcomes.  The objective was to 
develop an alternative system to analyse urine output and identify those at risk of developing 
severe oliguria.     
Design 
This was a retrospective cohort study utilising prospectively collected data.  
Setting 
A cardiac intensive care unit in the UK. 
Patients 
Patients undergoing cardiac surgery between January 2013 and November 2017 
Measurement and main results 
Patients were randomly assigned to development (n=981) and validation (n=2389) datasets.  
A patient-specific, dynamic Bayesian model was developed to predict future urine output.  
Model discrimination and calibration for predicting severe oliguria (<0.3ml/kg/hr for 6 hours) 
occurring within the next 12 hours were tested in the validation dataset at multiple time 
points. Patients with a high-risk (probability of severe oliguria >0.8) were identified and their 
outcomes were compared with those for low-risk patients and for patients who suffered AKI 
based on KDIGO urine output criteria.   
Model discrimination was excellent at all time points (AUC >0.9 for all).  Calibration of the 
model’s predictions was also excellent.  Multivariable logistic regression demonstrated that 
patients in the high-risk group were more likely to require renal replacement therapy (OR 
10.4, 95%CI 5.9-18.1), suffer prolonged hospital stay (OR 4.4, 95% CI 3.0-6.4) and die in 
hospital (OR 6.4, 95%CI 2.8-14.0) (p<0.001 for all).  Outcomes for those identified as high-
risk by the model were significantly worse than those classified as suffering AKI based on 
KDIGO urine output criteria.  
Conclusions 
This novel, patient-specific model accurately identifies patients at increased risk of severe 
oliguria.  Classification according to model predictions outperformed the KDIGO urine output 
criteria.  As the new model identifies patients at risk before severe oliguria develops it could 





Acute kidney injury (AKI) is defined and stratified by the KDIGO AKI guidelines(1) and occurs 
in up to 75% of patients in general intensive care units(2, 3) and up to 30% of patients 
following cardiac surgery(4).  The KDIGO guidelines stratify the severity of AKI based on 
serum creatinine concentration and urine output.  Studies in both cardiac surgery and 
general ICU patients have shown that the guidelines’ creatinine criteria successfully identify 
patients with increased risk of prolonged length of stay, short-term mortality and long term 
mortality.(3, 5-8)  However, there is less agreement about the value of the guidelines’ urine 
output criteria which define AKI as urine output below 0.5ml/kg/hr for more than 6 hours.  
Most large studies were unable to obtain enough urine output data to adequately assess the 
importance of the urine output criteria in the prediction of adverse outcomes.(3, 7, 8)  Some 
smaller studies demonstrated that calibration of the KDIGO urine output thresholds may be 
inadequate by showing that patients diagnosed with AKI by urine output alone had relatively 
good outcomes compared with those who also met the guideline’s serum creatinine 
criteria.(2, 9-11)  Ralib et al demonstrated that a urine output threshold of 0.3ml/kg/hr for 6 
hours (severe oliguria) was more closely associated with adverse outcomes in general ICU 
patients.(9)  However, use of this threshold rather than the 0.5ml/kg/hr for 6 hours threshold 
specified in the KDIGO stage 1 definitions could lead to adverse patient outcomes related to 
the 6 hours of marked oliguria required to before risk stratification could occur.  Dynamic 
Bayesian modelling(12, 13) has been used in related settings (14, 15) and could provide a 
solution to this problem by identifying those at greatest risk of severe oliguria early enough to 
allow treatment to be administered.  The objective of this study was to develop and validate 
a patient-specific dynamic Bayesian model which could run in real time to predict the risk of 
developing severe oliguria.  To confirm the clinical usefulness of the model, associations 
between those at a high predicted risk of severe oliguria and adverse outcomes were also 
investigated.  Outcomes of the high-risk group were also compared with patients who met 
existing KDIGO urine output criteria.    
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Materials and Methods 
Data 
Prospectively collected data from adult patients admitted to the cardiac intensive care unit 
(CICU) following cardiac surgery between January 2013 and November 2017 were 
analysed.  Patients receiving mechanical circulatory support (MCS) or cardiac 
transplantation were excluded.  Patients who received renal replacement therapy (RRT) 
preoperatively were also excluded.  
Hourly urine output values and the time of any decision to initiate RRT were extracted from 
the electronic patient record.   Only urine output data recorded before the initiation of RRT 
was analysed.   Outcome data was collected from the hospital’s clinical governance 
database.  All data were cleaned and stored in the Vascular Governance NorthWest 
(VGNW) database, handled according to the database’s ethical approvals and anonymised 
prior to analysis.  All data cleaning and analysis was performed using R Studio (R 
Foundation for statistical computing).(16) 
Model development 
Eligible patients were randomly assigned to either model development or model validation 
datasets in a ratio of 1:2.5 to ensure a development group of around 1000 patients.  A 
dynamic linear model was developed using data the development dataset.  The model 
analysed each patient’s own previous hourly urine output values and then from the 6th hour 
on CICU predicted that individual’s urine output for the next 6 hours.  The model produced 
updated predictions on an hourly basis throughout the CICU stay as each new measurement 
became available.  The probability of the next 6 hours’ urine output being below 0.3ml/kg/hr 
was calculated using Bayesian forecasting.   The model applied weightings to the 
contributions of urine output values according to how recent they were with the most recent 
values deemed the most relevant.  This allowed the forecast to update quickly in response to 
changing trends.  Model development is described in detail in the appendix. 
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Model validation (statistical analyses) 
It was recognised that for a subgroup of patients the model could potentially provide 
inappropriate reassurance to clinicians.  The model could predict a low risk of severe oliguria 
occurring within 6 hours and the patient could pass enough urine to prevent severe oliguria 
occurring within 6 hours but go on to suffer severe oliguria soon afterwards.  In this scenario 
while statistically correct, the model’s output could limit its clinical usefulness.  The validation 
analyses therefore tested the model’s ability to identify which patients would suffer severe 
oliguria (UO <0.3ml/kg/hr for 6 hours) within 12 hours of the prediction.  Risk classifications 
made during the last 12 hours of a patient’s admission were disregarded as it was not 
possible to confirm if severe oliguria subsequently occurred following discharge from CICU.  
Discrimination (the ability to distinguish those who would suffer severe oliguria from those 
who would not) was assessed using Receiver Operator Curve (ROC) analyses.   The 95% 
confidence intervals for the area under the curves (AUC) were calculated using DeLong’s 
method.(17) As the dataset was unbalanced (severe oliguria was relatively rare) precision 
recall curves were also used to test model performance.(18)  Calibration (how well predicted 
risk matched observed outcomes) was assessed using the ratio of observed to expected 
outcomes (O:E ratio) and calibration plots.(19)  The calibration plots show the observed and 
predicted risk of severe oliguria for patients grouped into twenty evenly sized groups 
according to their predicted risk.  For completeness, performance of the model when 
predicting severe oliguria limited to the six hours following predictions was also assessed 
with full results in the appendix. 
Although in clinical practice clinicians are likely to interpret the model’s continually updated 
risk predictions rather than a binary risk classification, to allow comparison of the model’s 
predictions with the existing categorical KDIGO classification, patients were assigned to 
either a high-risk or a low-risk group.  Patients for whom the probability of severe oliguria 
reached >0.8 during their stay were arbitrarily classified as high-risk and those who did not 
were classified as low-risk.  This relatively high threshold was selected a priori as the aim 
6 
 
was to produce a classification with a high specificity.  Associations between this 
classification and postoperative RRT, prolonged length of stay (PLOS) and hospital mortality 
were tested using univariable and multivariable analyses. Outcomes for patients grouped 
according to classification by the model and the KDIGO criterion were also compared.  
PLOS was defined as a hospital stay >10 days.  If RRT was initiated within three hours of 
CICU admission, the patient was excluded from the analyses as case note analyses 
revealed that all of these decisions to start RRT had been made during surgery before the 
patient arrived on CICU.  If the decision to initiate RRT was made before a high-risk 
classification, the patient was assigned to the low-risk group and the RRT was considered to 
have been administered to a low risk patient.  Univariable analyses were performed using 
the Chi Square test or Fisher’s exact test in the event of sparse data. Multivariable logistic 
regression was used to adjust for the confounding effects of pre- and perioperative variables 
associated with adverse outcomes using the extensively validated logistic EuroSCORE 
model. (20, 21) Cardiopulmonary bypass (CPB) time was used as a surrogate marker to 
adjust for intra-operative procedure complexity. 
The sensitivity, specificity, positive predictive value and negative predictive value of 
classification by the new model based on the arbitrary threshold of 0.8 for the identification of 
those at risk of subsequent RRT were calculated.  These values were compared with 
equivalent values obtained when classifying patients according to i) the KDIGO UO criterion 
(UO <0.5ml/kg/hr for 6 hours) and ii) observed severe oliguria (UO<0.3ml/kg/hr for 6 hours).  
Missing data 
Where hourly urine output was recorded as “0” this value was used.  Where hourly values 
were blank, the next recorded urine output was divided by the number of hours that had 
elapsed since the previous reading and this value was substituted for the blank values.  
Where this imputation resulted in urine output lower than the 0.5ml/kg for 6 hours the cases 
notes were examined and the urine output entries verified through entries in the nursing 
7 
 
notes.  Where weight was missing, the value was imputed using the median weight for a 
patient of that gender. 
Results 
In total 3,602 patients were admitted to CICU following cardiac surgery, 228 were excluded 
as they underwent cardiac transplantation or received  MCS and four patients were excluded 
as they received RRT preoperatively.  Of the eligible 3370 patients, 981 were randomly 
assigned to the development group and the remaining 2389 patients were assigned to the 
validation group.  The patient characteristics of each group are shown in Table 1.  Patient 
weight was missing for 13 (1.3%) and 23 (1.0%) patients in the development and validation 
cohorts respectively. 
In the validation cohort, 2088 (87.4%) patients suffered at least one hour of urine output 
below 0.3ml/kg/h. There were 197 (8.2%) patients who experienced severe oliguria and 89 
(3.7%) patients who required RRT.  In total, 4942 (2.8%) hourly urine output entries were 
missing and these values were imputed using the methods described in the previous 
section.  A total of 19 (0.8%) patients received RRT within three hours of arrival on CICU 
and these patients were excluded from the RRT analyses.  PLOS was observed in 589 
(24.7%) patients and 36 (1.5%) died prior to hospital discharge.  There were no missing 
outcome data. 
Predicting severe oliguria  
The Receiver operating characteristic curves for the prediction of severe oliguria within the 
next 12 hours for predictions made at 12, 24, 36, 48 and 72 hours are shown in Figure 1a.  
At each time point the AUC for the predictions was >0.9 representing excellent 
discrimination between those who did and did not go on to suffer severe oliguria within the 
next 12 hours. As illustrated by Figure 2 and the O:E ratios detailed in Table A1 of the 
appendix, calibration was also excellent.  
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The precision recall curves (Figures appendix 1) illustrate the trade-off between ensuring 
that every patient who will go on to suffer AKI is identified and that the number of false 
positives is minimised.  As shown in Figure appendix , as recall (also known as sensitivity) 
approaches 1 the Precision (positive predictive value) falls.  This effect was most 
pronounced for predictions made in the first 24 hours. 
Table A2 of the appendix describes the model’s performance when predicting severe oliguria 
occuring within 6 hours of prediction. Discriminination was consistently better than when 
predicting severe oliguira occuring within 12 hours following predictions but risk was 
consistenty overestimated.  Across the 5 time points analysed there were 258 incidences 
where a patient developed severe oliguria within 12 hours of predictions, however on 109 
occasions patients severe oliguria only developed between 7 and 12 hours after prediction.   
 
Classification task 
In the validation dataset 158 patients experienced a probability of severe oliguria >0.8 and 
were assigned to the high-risk group. The remaining 2231 patients were assigned to the low-
risk group.  Outcomes for these two groups are reported in Table A3.  High-risk patients 
experienced increased rates of subsequent RRT, PLOS and hospital mortality compared 
with those classified as low-risk (P<0.001 for all outcomes).  On multivariable analysis, high-
risk classification was associated with increased risk of RRT (OR 10.4, 95%CI 5.9-18.1), 
PLOS (OR 4.4, 95% CI 3.0-6.4) and hospital mortality (OR 6.4, 95%CI 2.8-14.0) (p<0.001 
for all outcomes).  The multivariable models used for risk adjustment are shown in the 
Appendix (Tables A4-A6).  The median (IQR) time from high-risk classification to the onset 
of severe oliguria of 3.0 (0.0-4.0) hours 
The KDIGO urine output criterion identified 628 patients (26.3%) as suffering AKI by urine 
output.  The outcomes for classification of risk using the new model and the KDIGO criterion 
are compared in Table 2.  Outcomes for those classified as being at high risk by the model 
9 
 
and those meeting the KDIGO criteria could not be compared directly as some patients 
would have been include in multiple groups.  Patients who met the KDIGO urine output 
criterion for AKI but were classified as low-risk by the model (n=506) experienced rates of 
RRT (3.6%), PLOS (34.8%) and mortality (2.4%) which were significantly lower than the 
risks for those classified as high-risk by the Bayesian model (p<0.001 for all).    When used 
to predict future RRT requirement, the Bayesian model achieved greater specificity and 
positive predictive value (but lower sensitivity) than the KDIGO AKI criterion.  The 
performance of the dynamic Bayesian model was almost identical to that achieved by 
classification according to actual observed oliguria.  (Table 3)   
Discussion 
This patient-specific Dynamic Bayesian model was developed and validated in separate 
cohorts which together contained high quality, prospectively-gathered data for over 3000 
patients. The model successfully identified patients at risk of severe oliguria demonstrating 
excellent discrimination and calibration at each time point. Outcomes were significantly 
worse for patients with a high-risk of severe oliguria than for those assigned to the low-risk 
group.  Those identified as high risk by the model also suffered worse outcomes than those 
who only met the KDIGO urine output criterion for AKI. 
The unbalanced nature of the data had the potential to make the AUC statistics seem overly 
impressive.  Indeed, precision recall curve analyses showed that the excellent discrimination 
identified on ROC curve analyses of predictions made at 12 and 24 hours was partly due to 
the large proportion of patients who did not suffer severe oliguria and whom the model 
identified as being at low risk of oliguria.  However, this effect was less significant for 
predictions made after this time.    
During the validation of predictions made at hours 12, 24, 36, 48 and 72, 109 incidences 
were identified in which a patient suffered severe oliguria between 7 and 12 hours following 
predictions.  In some cases it is likely that the model apprpriately predicted severe oliguira 
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would occur within 6 hours but an intervention such as a fluid challenge or a trial of diuretic 
therapy was impemented at this time.  In some patients the response would be transitory, 
causing a the urine output to rise briefly above the 0.3ml/kg/hr threshold before falling back 
to a lower level.  Such patients would therefore only meet the 0.3ml/kg/hour for 6 hours later.  
Nevertheless, these patients suffered an adverse event and the identifiction of such a 
significant number of incidences of severe oliguria occurring between hours 7 and 12 justies 
the selection of severe oliguira occurring with 12 hours of prediction as the outcome used 
when validating predictions. 
 
In clinical practice, classification into high and low-risk groups based on an arbitrary 
threshold is unlikely to be necessary and significantly diminishes the usefulness of the 
model.   Rather, patient monitoring software would analyse the individual’s urine output data 
in real-time and display updated estimates of the absolute risk of developing severe oliguria.  
This information, together with the trend of risk for that patient would inevitably be much 
more useful to a treating clinician than knowledge of the patient’s risk group.  
In this study a threshold was used to dichotomise the patients purely to allow the comparison 
of outcomes observed in patients classified as high and low-risk by the model.  The 
categorisation also allowed comparison of outcomes between patients classified as high-risk 
by the model and patients who met the existing KDIGO AKI criteria. The threshold used for 
the classification exercise was deliberately high at 0.8 to reduce the number of false positive 
high-risk classifications which are a weakness of the existing KDIGO AKI classification.(2, 9, 
10) As a result a large subgroup (n=506) met the KDIGO AKI criterion but were classified as 
low-risk by the model. Outcomes for these patients were significantly better than for the 
group classified as high-risk by the model suggesting that for a large proportion of those who 
meet the KDIGO urine output criterion risk of adverse outcomes is actually relatively low. 
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The significant increase in risk of adverse outcomes found to be associated with a predicted 
or observed fall in urine output to < 0.3ml/kg/hr for 6 hours is similar to that found in general 
ICU patients(9) and justifies the selection of this threshold in this study.  Risk stratification 
was not significantly improved when classification was made according to observed rather 
than predicted severe oliguria.  The main advantage of using the dynamic Bayesian model is 
that it provides reliable, early warnings of impending severe oliguria before it occurs, 
allowing time to deliver treatments to prevent the severe oliguria and its consequences.  
Even if a warning were only raised when a probability of 0.8 for severe oliguria was reached 
- as in our classification exercise – this would allow interventions aimed at preserving renal 
function.  In reality patients for whom risk of severe oliguria is increasing are likely to be 
reviewed before a probability of 0.8 is reached, affording even more time for intervention. 
Clinical use of a urine output screening protocol which employs this dynamic Bayesian 
model is perfectly feasible because although mathematically complex, the model is 
computationally inexpensive and can run on standard computers or tablets available at the 
bedside. The model uses the trend of urine output rather than comparison of point values 
against arbitrary thresholds.  The progressive decline in urine output towards the defined 
threshold of 0.3ml/kg is intuitively more relevant than the occurrence of a point value below 
an arbitrary “normal”.  Indeed, over 85% of those classified as low-risk suffered at least one 
hour of urine output below 0.3ml/kg/hr but this group had excellent outcomes.  As the only 
data required by the model are patient weight and hourly urine output values, the model 
should be transferrable across all patients on critical care units.  In this study we chose to 
calculate the probability of urine output dropping below 0.3ml/kg/hr but this threshold could 
be altered to suit different patient cohorts.   Under these circumstances the model could be 
useful across a range of settings, alerting clinicians to the risk of urine output dropping below 
a threshold they consider to be clinically significant.  
While these results are encouraging, analyses of urine output alone cannot identify all 
patients at risk of adverse outcomes related to renal dysfunction.  Indeed, 41 patients 
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received RRT despite being classified as low-risk because their urine output was maintained 
around or above 0.3ml/kg/hr.  Analysis of the EPR for these patients, identified deranged 
biochemistry (elevated urea and/or creatinine concentrations, hyperkalaemia or metabolic 
acidosis) (n=31), fluid overload (n=16), hyperlactataemia (n=4) and sepsis (n=1) as the 
indications for RRT initiation.  In addition, while the novel model accurately predicted severe 
oliguria, less than 20% of those who suffered severe oliguria went on to require RRT.  
Currently, creatinine concentration performs a key role in the identification of those at risk of 
adverse outcomes related to renal dysfunction.  The existing KDIGO(1) creatinine criteria - 
which are shared by the AKIN and RIFLE guidelines (22, 23) - have been shown to stratify 
risk accurately in both cardiac surgery patients (24, 25) and the general inpatient population 
(26, 27).  Similarly, recent advances in the use of biomarkers have been shown to enable 
the early identification of those at increased risk of adverse outcomes related to renal 
dysfunction (28-30).  Moreover, the combination of biomarkers and serum creatinine 
analyses increases the accuracy of patient risk classification. (29, 30)  Future work should 
focus on integrating the novel analysis of urine output described in this study with other 
physiological variables measured in real-time together with biomarker and serum creatinine 
results to optimise the early detection of deranged renal physiology. 
Limitations  
Most patients in this study received interventions with the intention of normalising urine 
output. A total of 488 (20.4%) patients received diuretics during their ICU admission. Data on 
the success of such interventions has not been investigated as part of this study but is likely 
to be of value as part of future work. The development of this model benefited from being 
conducted in a group of patients undergoing cardiac surgery in one institution where the risk 
of complications is well known but the single centre design could limit transferability across 
other health care settings.  The methodology developed will therefore need to be validated in 
different patient groups and in different institutions. With appropriate development, it could 
easily be applicable to all intensive care unit patients.  The ability of the model to improve 
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patient outcome through early recognition of impending severe oliguria should then be 
tested. 
Conclusions 
This dynamic Bayesian model, which analyses a patient’s current urine output in the context 
of their previous urine output, can be used to accurately predict the risk of severe oliguria 
occurring within the next 12 hours.  Classification according to the model’s predictions was 
shown to outperform the current method for screening patient urine output; the KDIGO AKI 
criteria. Crucially, the use of dynamic Bayesian modelling allows those at high-risk to be 
identified before they suffer a prolonged period of severe oliguria and in time to offer 
treatment.  The model requires no additional information other than hourly urine output 
values and the patient’s weight, can be easily run by computers routinely available at the 
bedside and provides an output that is easily interpreted by the clinical team. Before 
widespread adoption, the model requires validation in a range of critical care units and 
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Figure 1 Legend.  Receiver operating characteristic curves for the prediction of severe 
oliguria (<0.3ml/kg/hr for 6 hours) during the next 12 hours following each predictions made 
by the model at 12, 24, 36, 48 and 72 hours. 
Figure 2 Legend. Calibration plots for the Bayesian model’s prediction of severe oliguria 
(0.3ml/kg/hr for 6 hours) during the next 12 hours at a)12 hours, b)24 hours, c)36 hours, 
d)48 hours and e)72 hours.  Patients were grouped into deciles according to predicted risk.  





































Table 1 – Patient Characteristics 
Characteristic Development group (n=981) Validation group (=2389) 
Age, mean (sd) , years 66.4 (11.2) 66.7 (10.9) 
Female gender, % 279 (28.2) 660 (27.6) 
Weight, mean (sd), Kg 82.2 (15.9) 81.8 (16.4) 
Logistic EuroSCORE, median 
(Interquartile range) 
3.8 (2.1-7.4) 3.7 (2.0-7.0) 
Operation, n (%)   
  CABG  544 (55.5) 1394 (58.4) 
  Valve 227 (23.1) 505 (21.1) 
  CABG and Valve 125 (12.7) 337 (14.1) 
  Aortic 65 (6.6) 118 (5.0) 
  Other – minor 3 (0.3) 5 (0.2) 
  Other – major 17 (1.7) 30 (1.3) 
Urgency, n (%)   
  Elective 574 (58.5) 1380 (57.8) 
  Urgent 395 (40.3) 958( 40.1) 
  Emergency 9 (0.9) 44 (1.8) 
  Salvage 3 (0.3) 7 (0.3) 
CPB time, median (Interquartile 
range), minutes 















Table 2 – Outcomes for patients grouped according to risk level as determined by analysis of 
urine output by KDIGO-AKI guideline and the Bayesian model. 
 
Group N (% of total)* RRT, N (%) PLOS, N (%)  Hospital mortality, N(%) 
Low-risk by model 
and no KDIGO AKI  1725 (72.2%) 15 (0.9) 320 (18.6) 10 (0.6) 
Low-risk by model but  
KDIGO AKI  506 (21.2) 18 (3.6) 176 (34.8) 12 (2.4) 
High-risk by model 
but no KDIGO AKI  36 (1.5) 3 (8.3) 30(83.3) 3 (8.3) 
High-risk by model 
and KDIGO AKI  122 (5.1) 26 (21.3) 73 (59.8) 11 (9.0) 
KDIGO =Kidney Disease Improving Global Outcomes,  UO = urine output, AKI = Acute 
Kidney Injury, PLOS = prolonged length of stay in hospital, RRT = renal replacement therapy 
 
 
Table 3 - Performance of the Bayesian model, existing KDIGO AKI-UO criterion and severe 
oliguria when identifying those at risk of RRT. 
Classification 
Method 
Sensitivity Specificity Positive Predictive Value Negative Predictive Value 
AKI-UO 0.74 0.75 0.08 0.99 
Model 0.41 0.94 0.18 0.98 
Severe oliguria 0.41 0.94 0.18 0.98 
Severe oliguria = observed UO <0.3ml/kg for 6 hours,  AKI-UO = observed UO <0.5ml/kg for 









Table A1 – Comparison of observed outcomes and model’s predictions for severe oliguria  
Time point (number of 
patients still on CICU) 
Observed severe 
oliguria within 12 hours, 
n(%) 
Predicted severe oliguria 
within 12 hours, n(%) 
O:E 
ratio 
12 hours (1947) 61 (3.1) 82 (4.2) 0.74 
24 hours (1694) 57 (3.4) 61 (3.6) 0.93 
36 hours (1137) 51 (4.5) 44 (3.9) 1.16 
48 hours (909) 54 (5.9) 48(5.3) 1.13 
72 hours (545) 35 (6.4) 30 (5.6) 1.15 
 
Table A2 - Performance of models when predicting severe oliguria occurring with the next 6 hours 
Time point (number of 
patients still on CICU) 
AUC (95% CI) Observed 
severe oliguria 
within 6 hours 
Predicted 
severe oliguria 
within 6 hours 
O:E 
ratio 
12 hours 0.98 (0.96-0.99) 21 90 0.23 
24 hours 0.98 (0.97-0.99) 30 61 0.49 
36 hours 0.99 (0.98-1.00) 34 49 0.69 
48 hours 0.99 (0.98-1.00) 36 49 0.73 
72 hours 0.99 (0.98-1.00) 38 31 0.92 
 
 
Table A3 -Outcome of patients according to classification by the Bayesian model 
Group RRT (n,%) PLOS (n,%) Mortality (n,%) 
High-risk (n=158) 29(18.4)* 93 (58.9) * 14 (8.9) * 
Low-risk (n=2231) 41(1.8%) 496 (22.2) 22 (1.0)  
 p<0.001 when compared to low-risk classification by the model 








Logistic regression models used to adjust for confounders during multivariable analyses 
 
Table A4 – Model for prediction of Renal replacement therapy  
Variable Beta coefficient Odds ratio 95% CI for Odds 
ratio 
P value 
Intercept -4.53   <0.001 
Model high-risk 
classification 
2.34 10.36 5.86-18.07 <0.001 
Logistic 
EuroSCORE 
0.04 1.03 1.01-1.06 <0.001 




Table A5 – Model for prediction of prolonged length of stay 
Variable Beta coefficient Odds ratio 95% CI for Odds 
ratio 
P value 
Intercept -2.41   <0.001 
Model high-risk 
classification 
1.48 4.38 2.99-6.44 <0.001 
Logistic 
EuroSCORE 
0.07 1.08 1.06-1.09 <0.001 
CPB (minutes) 0.01 1.00 1.00-1.01 <0.001 
  
 
Table A6 – Model for prediction of hospital mortality 
Variable Beta coefficient Odds ratio 95% CI for Odds 
ratio 
P value 
Intercept -6.13   <0.001 
Model high-risk 
classification 
1.86 6.44 2.82-13.98 <0.001 
Logistic 
EuroSCORE 
0.03 1.03 1.00-1.05 0.06 
CPB (minutes) 0.01 1.01 1.00-1.01 <0.001 
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